Reviews18 March 2014
A Systematic Review and Meta-analysis
    Author, Article, and Disclosure Information



    Guidelines advocate changes in fatty acid consumption to promote cardiovascular health.


    To summarize evidence about associations between fatty acids and coronary disease.

    Data Sources:

    MEDLINE, Science Citation Index, and Cochrane Central Register of Controlled Trials through July 2013.

    Study Selection:

    Prospective, observational studies and randomized, controlled trials.

    Data Extraction:

    Investigators extracted data about study characteristics and assessed study biases.

    Data Synthesis:

    There were 32 observational studies (512 420 participants) of fatty acids from dietary intake; 17 observational studies (25 721 participants) of fatty acid biomarkers; and 27 randomized, controlled trials (105 085 participants) of fatty acid supplementation. In observational studies, relative risks for coronary disease were 1.03 (95% CI, 0.98 to 1.07) for saturated, 1.00 (CI, 0.91 to 1.10) for monounsaturated, 0.87 (CI, 0.78 to 0.97) for long-chain ω-3 polyunsaturated, 0.98 (CI, 0.90 to 1.06) for ω-6 polyunsaturated, and 1.16 (CI, 1.06 to 1.27) for trans fatty acids when the top and bottom thirds of baseline dietary fatty acid intake were compared. Corresponding estimates for circulating fatty acids were 1.06 (CI, 0.86 to 1.30), 1.06 (CI, 0.97 to 1.17), 0.84 (CI, 0.63 to 1.11), 0.94 (CI, 0.84 to 1.06), and 1.05 (CI, 0.76 to 1.44), respectively. There was heterogeneity of the associations among individual circulating fatty acids and coronary disease. In randomized, controlled trials, relative risks for coronary disease were 0.97 (CI, 0.69 to 1.36) for α-linolenic, 0.94 (CI, 0.86 to 1.03) for long-chain ω-3 polyunsaturated, and 0.86 (CI, 0.69 to 1.07) for ω-6 polyunsaturated fatty acid supplementations.


    Potential biases from preferential publication and selective reporting.


    Current evidence does not clearly support cardiovascular guidelines that encourage high consumption of polyunsaturated fatty acids and low consumption of total saturated fats.

    Primary Funding Source:

    British Heart Foundation, Medical Research Council, Cambridge National Institute for Health Research Biomedical Research Centre, and Gates Cambridge.


    • 1. McNaught ADWilkinson ACompendium of Chemical Terminology. 2nd ed. New York: Blackwell Scientific; 1997. Google Scholar
    • 2. Ratnayake WMGalli CFat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann Nutr Metab2009;55:8-43. [PMID: 19752534] CrossrefMedlineGoogle Scholar
    • 3. Campbell MKFarrell OSBiochemistry. 5th ed. Florence, KY: Cengage Learning; 2006. Google Scholar
    • 4. Gidding SSLichtenstein AHFaith MSKarpyn AMennella JAPopkin Bet alImplementing American Heart Association pediatric and adult nutrition guidelines: a scientific statement from the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research. Circulation2009;119:1161-75. [PMID: 19255356] MedlineGoogle Scholar
    • 5. Mozaffarian DWilson PWKannel WBBeyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation2008;117:3031-8. [PMID: 18541753] CrossrefMedlineGoogle Scholar
    • 6. EURODIET Core Report. Nutrition & Diet for Healthy Lifestyles in Europe. Accessed at on 18 July 2013. Google Scholar
    • 7. Stanner SCardiovascular Disease: Diet, Nutrition and Emerging Risk Factors. 1st ed. Oxford, United Kingdom: Blackwell Publishing; 2005. Google Scholar
    • 8. Joint World Health Organization/Food and Agriculture Organization Expert Consultation. Diet, Nutrition and the Prevention of Chronic Disease. Accessed at on 18 July 2013. Google Scholar
    • 9. National Institute for Health and Care Excellence. PH25: Prevention of cardiovascular disease. Accessed at on 18 July 2013. Google Scholar
    • 10. Perk JDe Backer GGohlke HGraham IReiner ZVerschuren Met alEuropean Association for Cardiovascular Prevention & Rehabilitation (EACPR)European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J2012;33:1635-701. [PMID: 22555213] MedlineGoogle Scholar
    • 11. Smit LAMozaffarian DWillett WReview of fat and fatty acid requirements and criteria for developing dietary guidelines. Ann Nutr Metab2009;55:44-55. [PMID: 19752535] CrossrefMedlineGoogle Scholar
    • 12. Siri-Tarino PWSun QHu FBKrauss RMMeta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr2010;91:535-46. [PMID: 20071648] CrossrefMedlineGoogle Scholar
    • 13. Goris AHWesterterp-Plantenga MSWesterterp KRUndereating and underrecording of habitual food intake in obese men: selective underreporting of fat intake. Am J Clin Nutr2000;71:130-4. [PMID: 10617957] CrossrefMedlineGoogle Scholar
    • 14. Hebert JRClemow LPbert LOckene ISOckene JKSocial desirability bias in dietary self-report may compromise the validity of dietary intake measures. Int J Epidemiol1995;24:389-98. [PMID: 7635601] CrossrefMedlineGoogle Scholar
    • 15. Johansson LSolvoll KBjørneboe GEDrevon CAUnder- and overreporting of energy intake related to weight status and lifestyle in a nationwide sample. Am J Clin Nutr1998;68:266-74. [PMID: 9701182] CrossrefMedlineGoogle Scholar
    • 16. Bingham SALuben RWelch AWareham NKhaw KTDay NAre imprecise methods obscuring a relation between fat and breast cancer? Lancet2003;362:212-4. [PMID: 12885485] CrossrefMedlineGoogle Scholar
    • 17. Willett WCNutritional epidemiology issues in chronic disease at the turn of the century. Epidemiol Rev2000;22:82-6. [PMID: 10939011] CrossrefMedlineGoogle Scholar
    • 18. Baylin ACampos HThe use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol2006;17:22-7. [PMID: 16407712] CrossrefMedlineGoogle Scholar
    • 19. Erkkilä Ade Mello VDRisérus ULaaksonen DEDietary fatty acids and cardiovascular disease: an epidemiological approach. Prog Lipid Res2008;47:172-87. [PMID: 18328267] CrossrefMedlineGoogle Scholar
    • 20. Riboli ERönnholm HSaracci RBiological markers of diet. Cancer Surv1987;6:685-718. [PMID: 2838169] MedlineGoogle Scholar
    • 21. Ramsden CEZamora DLeelarthaepin BMajchrzak-Hong SFFaurot KRSuchindran CMet alUse of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:8707. [PMID: 23386268] CrossrefMedlineGoogle Scholar
    • 22. Rizos ECNtzani EEBika EKostapanos MSElisaf MSAssociation between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA2012;308:1024-33. [PMID: 22968891] CrossrefMedlineGoogle Scholar
    • 23. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed at on 21 October 2013. Google Scholar
    • 24. Higgins JPAltman DGGøtzsche PCJüni PMoher DOxman ADet alCochrane Bias Methods GroupThe Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928. [PMID: 22008217] CrossrefMedlineGoogle Scholar
    • 25. Danesh JCollins RAppleby PPeto RAssociation of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA1998;279:1477-82. [PMID: 9600484] CrossrefMedlineGoogle Scholar
    • 26. Clarke RFrost CCollins RAppleby PPeto RDietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ1997;314:112-7. [PMID: 9006469] CrossrefMedlineGoogle Scholar
    • 27. Higgins JPThompson SGDeeks JJAltman DGMeasuring inconsistency in meta-analyses. BMJ2003;327:557-60. [PMID: 12958120] CrossrefMedlineGoogle Scholar
    • 28. Egger MDavey Smith GSchneider MMinder CBias in meta-analysis detected by a simple, graphical test. BMJ1997;315:629-34. [PMID: 9310563] CrossrefMedlineGoogle Scholar
    • 29. Manson JEBassuk SSLee IMCook NRAlbert MAGordon Det alThe vitamin d and omega-3 trial (vital): Rationale and design of a large randomized controlled trial of vitamin d and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials2012;33:159-71. [PMID: 21986389] CrossrefMedlineGoogle Scholar
    • 30. Poppitt SDSwann DBlack AEPrentice AMAssessment of selective under-reporting of food intake by both obese and non-obese women in a metabolic facility. Int J Obes Relat Metab Disord1998;22:303-11. [PMID: 9578234] CrossrefMedlineGoogle Scholar
    • 31. Kobayashi MSasaki SKawabata THasegawa KTsugane SJPHCValidity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I to assess fatty acid intake: comparison with dietary records and serum phospholipid level. J Epidemiol2003;13:S64-81. [PMID: 12701633] CrossrefMedlineGoogle Scholar
    • 32. Rimm EBGiovannucci ELStampfer MJColditz GALitin LBWillett WCReproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol1992;135:1114-26; discussion 1127-36. [PMID: 1632423] CrossrefMedlineGoogle Scholar
    • 33. Parks EJHellerstein MKCarbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr2000;71:412-33. [PMID: 10648253] CrossrefMedlineGoogle Scholar
    • 34. Forsythe CEPhinney SDFeinman RDVolk BMFreidenreich DQuann Eet alLimited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids2010;45:947-62. [PMID: 20820932] CrossrefMedlineGoogle Scholar
    • 35. Merchant ATKelemen LEde Koning LLonn EVuksan VJacobs Ret alSHARE and SHARE-AP investigatorsInterrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis. Am J Clin Nutr2008;87:168-74. [PMID: 18175752] CrossrefMedlineGoogle Scholar
    • 36. Forsythe CEPhinney SDFernandez MLQuann EEWood RJBibus DMet alComparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids2008;43:65-77. [PMID: 18046594] CrossrefMedlineGoogle Scholar
    • 37. Siri PWKrauss RMInfluence of dietary carbohydrate and fat on LDL and HDL particle distributions. Curr Atheroscler Rep2005;7:455-9. [PMID: 16256003] CrossrefMedlineGoogle Scholar
    • 38. Hodson LSkeaff CMFielding BAFatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res2008;47:348-80. [PMID: 18435934] CrossrefMedlineGoogle Scholar
    • 39. Wennberg MVessby BJohansson IEvaluation of relative intake of fatty acids according to the Northern Sweden FFQ with fatty acid levels in erythrocyte membranes as biomarkers. Public Health Nutr2009;12:1477-84. [PMID: 19144238] CrossrefMedlineGoogle Scholar
    • 40. Wolk AVessby BLjung HBarrefors PEvaluation of a biological marker of dairy fat intake. Am J Clin Nutr1998;68:291-5. [PMID: 9701185] CrossrefMedlineGoogle Scholar
    • 41. Khaw KTFriesen MDRiboli ELuben RWareham NPlasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med2012;9:1001255. [PMID: 22802735] CrossrefMedlineGoogle Scholar
    • 42. Degirolamo CShelness GSRudel LLLDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat. J Lipid Res2009;50 Suppl S434-9. [PMID: 19029117] CrossrefMedlineGoogle Scholar
    • 43. Gillingham LGHarris-Janz SJones PJDietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids2011;46:209-28. [PMID: 21308420] CrossrefMedlineGoogle Scholar
    • 44. Lucas LRussell AKeast RMolecular mechanisms of inflammation. Anti-inflammatory benefits of virgin olive oil and the phenolic compound oleocanthal. Curr Pharm Des2011;17:754-68. [PMID: 21443487] CrossrefMedlineGoogle Scholar
    • 45. Mozaffarian DLemaitre RNKing IBSong XSpiegelman DSacks FMet alCirculating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the Cardiovascular Health Study: a cohort study. Ann Intern Med2011;155:160-70. [PMID: 21810709] LinkGoogle Scholar